| Item Type | Name |
|
Concept
|
Adjuvants, Immunologic
|
|
Concept
|
Aminocaproates
|
|
Concept
|
Acetylation
|
|
Concept
|
Antibodies, Neoplasm
|
|
Concept
|
Aged, 80 and over
|
|
Concept
|
alpha-Fetoproteins
|
|
Concept
|
Australia
|
|
Concept
|
Acrylamides
|
|
Concept
|
Adolescent
|
|
Concept
|
Acetylcysteine
|
|
Concept
|
Bile Ducts, Intrahepatic
|
|
Concept
|
Aged
|
|
Concept
|
Analgesics, Opioid
|
|
Concept
|
Amino Acid Sequence
|
|
Concept
|
Adenosine Triphosphate
|
|
Concept
|
Adult
|
|
Concept
|
Antithrombin III
|
|
Concept
|
Carbazoles
|
|
Concept
|
Antiviral Agents
|
|
Concept
|
Carcinoid Tumor
|
|
Concept
|
Chromosomes, Human, Pair 11
|
|
Concept
|
Chromosomes, Human, Pair 6
|
|
Concept
|
Antioxidants
|
|
Concept
|
Analysis of Variance
|
|
Concept
|
Anesthetics
|
|
Concept
|
Antibodies, Anti-Idiotypic
|
|
Concept
|
Antibodies, Monoclonal
|
|
Concept
|
B-Lymphocytes
|
|
Concept
|
Base Sequence
|
|
Concept
|
Benzamides
|
|
Concept
|
Benzimidazoles
|
|
Concept
|
Bayes Theorem
|
|
Concept
|
Benzocycloheptenes
|
|
Concept
|
Benzopyrans
|
|
Concept
|
Binding Sites
|
|
Concept
|
Drug Tolerance
|
|
Concept
|
Bilirubin
|
|
Concept
|
Bile Duct Neoplasms
|
|
Concept
|
Cattle
|
|
Concept
|
Child
|
|
Concept
|
Ethanolamines
|
|
Concept
|
Fertility
|
|
Concept
|
Chromosomes, Human, Pair 21
|
|
Concept
|
Catalase
|
|
Concept
|
Chromosomes, Human, Pair 12
|
|
Concept
|
Cell Transformation, Neoplastic
|
|
Concept
|
Cisplatin
|
|
Concept
|
Glucosephosphate Dehydrogenase
|
|
Concept
|
Haptoglobins
|
|
Concept
|
Diabetes Mellitus, Type 1
|
|
Concept
|
Heterocyclic Compounds, 3-Ring
|
|
Concept
|
Dacarbazine
|
|
Concept
|
Cross Reactions
|
|
Concept
|
Imidazoles
|
|
Concept
|
Dimethyl Sulfoxide
|
|
Concept
|
Drug Synergism
|
|
Concept
|
Emigration and Immigration
|
|
Concept
|
Child, Preschool
|
|
Concept
|
Cyclophosphamide
|
|
Concept
|
Growth Inhibitors
|
|
Concept
|
Chromones
|
|
Concept
|
Chromosomes, Human, Pair 9
|
|
Concept
|
Mammary Neoplasms, Experimental
|
|
Concept
|
Erythropoietin
|
|
Concept
|
Etoposide
|
|
Concept
|
Drug Interactions
|
|
Concept
|
Drug Resistance
|
|
Concept
|
Fluorescence Polarization
|
|
Concept
|
Melanoma, Experimental
|
|
Concept
|
Metalloporphyrins
|
|
Concept
|
Indoles
|
|
Concept
|
Microtubule-Associated Proteins
|
|
Concept
|
Fluorouracil
|
|
Concept
|
Myasthenia Gravis
|
|
Concept
|
Glioma
|
|
Concept
|
Glycosylation
|
|
Concept
|
Glioblastoma
|
|
Concept
|
Fibroblast Growth Factors
|
|
Concept
|
Neoplasms, Multiple Primary
|
|
Concept
|
Jejunal Neoplasms
|
|
Concept
|
Obesity
|
|
Concept
|
DNA Topoisomerases, Type I
|
|
Concept
|
Dose-Response Relationship, Drug
|
|
Concept
|
Dyspnea
|
|
Concept
|
Hydrogen Peroxide
|
|
Concept
|
Liver Neoplasms
|
|
Concept
|
Immunologic Capping
|
|
Concept
|
Insulin-Like Growth Factor I
|
|
Concept
|
Enzyme-Linked Immunosorbent Assay
|
|
Concept
|
Herpesvirus 4, Human
|
|
Concept
|
Fibrinopeptide A
|
|
Concept
|
Flow Cytometry
|
|
Concept
|
Fluorescent Antibody Technique
|
|
Concept
|
Infant
|
|
Concept
|
Multigene Family
|
|
Concept
|
Goats
|
|
Concept
|
Leukocytes, Mononuclear
|
|
Concept
|
Macrophages
|
|
Concept
|
Keratins
|
|
Concept
|
Carcinoma, Hepatocellular
|
|
Concept
|
Leukocytes
|
|
Concept
|
Mice, Inbred Strains
|
|
Concept
|
Pilot Projects
|
|
Concept
|
Mice, Transgenic
|
|
Concept
|
Neoplasm Transplantation
|
|
Concept
|
Poly(ADP-ribose) Polymerases
|
|
Concept
|
Pregnancy
|
|
Concept
|
Immunohistochemistry
|
|
Concept
|
Indazoles
|
|
Concept
|
Molecular Sequence Data
|
|
Concept
|
NADP
|
|
Concept
|
Neoplastic Cells, Circulating
|
|
Concept
|
Purpura, Thrombocytopenic
|
|
Concept
|
Oxidative Phosphorylation
|
|
Concept
|
Palliative Care
|
|
Concept
|
Pancreatic Neoplasms
|
|
Concept
|
Mesothelioma
|
|
Concept
|
Methotrexate
|
|
Concept
|
Mice, Inbred BALB C
|
|
Concept
|
Mice, Inbred C57BL
|
|
Concept
|
Mice, Nude
|
|
Concept
|
Middle Aged
|
|
Concept
|
Molecular Biology
|
|
Concept
|
Cricetinae
|
|
Concept
|
Peptide Fragments
|
|
Concept
|
Rhabdomyosarcoma
|
|
Concept
|
Interleukin-3
|
|
Concept
|
Myositis
|
|
Concept
|
Neuralgia
|
|
Concept
|
L-Lactate Dehydrogenase
|
|
Concept
|
Ovarian Neoplasms
|
|
Concept
|
Lipopolysaccharides
|
|
Concept
|
Liver
|
|
Concept
|
Lymphokines
|
|
Concept
|
Safety
|
|
Concept
|
Perfusion
|
|
Concept
|
Peptides, Cyclic
|
|
Concept
|
Microcirculation
|
|
Concept
|
Monensin
|
|
Concept
|
Phosphorylation
|
|
Concept
|
Phosphoserine
|
|
Concept
|
Morpholines
|
|
Concept
|
Motivation
|
|
Concept
|
Pleura
|
|
Concept
|
Orbital Diseases
|
|
Concept
|
Population Surveillance
|
|
Concept
|
Poverty Areas
|
|
Concept
|
Preoperative Care
|
|
Concept
|
Prostatic Neoplasms
|
|
Concept
|
Thymoma
|
|
Concept
|
Pleural Neoplasms
|
|
Concept
|
Protein-Tyrosine Kinases
|
|
Concept
|
Protein Processing, Post-Translational
|
|
Concept
|
Proto-Oncogene Proteins
|
|
Concept
|
Glutamates
|
|
Concept
|
Immunoenzyme Techniques
|
|
Concept
|
Rats, Inbred F344
|
|
Concept
|
Regression Analysis
|
|
Concept
|
Guanine
|
|
Concept
|
Rabbits
|
|
Concept
|
Radiation-Sensitizing Agents
|
|
Concept
|
Risk Factors
|
|
Concept
|
Protein Kinases
|
|
Concept
|
Prothrombin Time
|
|
Concept
|
Quinolines
|
|
Concept
|
Receptors, Antigen, B-Cell
|
|
Concept
|
Rotenone
|
|
Concept
|
Self Care
|
|
Concept
|
Nocodazole
|
|
Concept
|
Lactams
|
|
Concept
|
Respiratory Insufficiency
|
|
Concept
|
Risk
|
|
Concept
|
Histones
|
|
Concept
|
Humans
|
|
Concept
|
Leukocyte Count
|
|
Concept
|
Linear Models
|
|
Concept
|
Endothelial Growth Factors
|
|
Concept
|
Tomography, Emission-Computed
|
|
Concept
|
Tomography, X-Ray Computed
|
|
Concept
|
Protein Biosynthesis
|
|
Concept
|
Tissue Banks
|
|
Concept
|
Superoxides
|
|
Concept
|
Thionucleotides
|
|
Concept
|
Thymidine Kinase
|
|
Concept
|
Thymus Neoplasms
|
|
Concept
|
Oncogene Proteins v-abl
|
|
Concept
|
Caenorhabditis elegans
|
|
Concept
|
Hepatocyte Growth Factor
|
|
Concept
|
Practice Guidelines as Topic
|
|
Concept
|
Receptors, Opioid, mu
|
|
Concept
|
Drug Design
|
|
Concept
|
Protein Engineering
|
|
Concept
|
Radiation Pneumonitis
|
|
Concept
|
Vaccination
|
|
Concept
|
Phosphotransferases (Alcohol Group Acceptor)
|
|
Concept
|
Multicenter Studies as Topic
|
|
Concept
|
Leukemia, Lymphocytic, Chronic, B-Cell
|
|
Concept
|
Liver Neoplasms, Experimental
|
|
Concept
|
Carcinoma, Neuroendocrine
|
|
Concept
|
Transducin
|
|
Concept
|
Oncogene Proteins
|
|
Concept
|
Oncogene Proteins, Fusion
|
|
Concept
|
Proportional Hazards Models
|
|
Concept
|
Risk Assessment
|
|
Concept
|
Carcinoma, Lewis Lung
|
|
Concept
|
Drug Resistance, Neoplasm
|
|
Concept
|
Radiopharmaceuticals
|
|
Concept
|
Reverse Transcriptase Polymerase Chain Reaction
|
|
Concept
|
Caspases
|
|
Concept
|
Guanine Nucleotide Exchange Factors
|
|
Concept
|
Son of Sevenless Proteins
|
|
Concept
|
Tyrosine
|
|
Concept
|
Vitamin E Deficiency
|
|
Concept
|
rac1 GTP-Binding Protein
|
|
Concept
|
Mitogen-Activated Protein Kinases
|
|
Concept
|
Carboplatin
|
|
Concept
|
Transforming Growth Factor beta
|
|
Concept
|
Central Nervous System Neoplasms
|
|
Concept
|
Vacuolar Proton-Translocating ATPases
|
|
Concept
|
Up-Regulation
|
|
Concept
|
Quinolones
|
|
Concept
|
Radiosurgery
|
|
Concept
|
Lymph Nodes
|
|
Concept
|
Lymphatic Metastasis
|
|
Concept
|
Microscopy
|
|
Concept
|
Milk Proteins
|
|
Concept
|
Mitochondria
|
|
Concept
|
Mortality
|
|
Concept
|
Multiple Myeloma
|
|
Concept
|
Interleukin-8
|
|
Concept
|
Lymphocytes, Tumor-Infiltrating
|
|
Concept
|
Proto-Oncogene Proteins c-fos
|
|
Concept
|
Cytochalasin D
|
|
Concept
|
Comorbidity
|
|
Concept
|
Mutagenesis, Site-Directed
|
|
Concept
|
Hematopoietic Cell Growth Factors
|
|
Concept
|
Neoplasms, Unknown Primary
|
|
Concept
|
Neuropeptides
|
|
Concept
|
Proto-Oncogene Proteins c-abl
|
|
Concept
|
Receptors, Eph Family
|
|
Concept
|
Prostate-Specific Antigen
|
|
Concept
|
Protein Structure, Tertiary
|
|
Concept
|
Melanoma
|
|
Concept
|
Meningeal Neoplasms
|
|
Concept
|
Methionine
|
|
Concept
|
Microtubules
|
|
Concept
|
Paraffin Embedding
|
|
Concept
|
Myocarditis
|
|
Concept
|
Neoplasm Metastasis
|
|
Concept
|
Neoplasm Recurrence, Local
|
|
Concept
|
Neoplasms, Experimental
|
|
Concept
|
Integrin alpha5beta1
|
|
Concept
|
Angiogenic Proteins
|
|
Concept
|
Ubiquitin Thiolesterase
|
|
Concept
|
Oligodeoxyribonucleotides
|
|
Concept
|
RNA-Binding Proteins
|
|
Concept
|
Point Mutation
|
|
Concept
|
Interferon-alpha
|
|
Concept
|
Antibodies, Bispecific
|
|
Concept
|
Mice, Knockout
|
|
Concept
|
Crystallography, X-Ray
|
|
Concept
|
DNA, Complementary
|
|
Concept
|
Chemokines
|
|
Concept
|
Phosphotyrosine
|
|
Concept
|
Oxidative Stress
|
|
Concept
|
Disease Progression
|
|
Concept
|
Telomerase
|
|
Concept
|
Muscle, Skeletal
|
|
Concept
|
ras Proteins
|
|
Concept
|
Microscopy, Video
|
|
Concept
|
Proto-Oncogene Proteins c-crk
|
|
Concept
|
Apoptosis Regulatory Proteins
|
|
Concept
|
Carcinoma, Ductal, Breast
|
|
Concept
|
CA-125 Antigen
|
|
Concept
|
Proto-Oncogene Proteins c-vav
|
|
Concept
|
Hippocalcin
|
|
Concept
|
Tyrphostins
|
|
Concept
|
Antineoplastic Agents, Alkylating
|
|
Concept
|
src-Family Kinases
|
|
Concept
|
Angiogenesis Inhibitors
|
|
Concept
|
GTP-Binding Protein alpha Subunits, Gi-Go
|
|
Concept
|
BRCA1 Protein
|
|
Concept
|
Particulate Matter
|
|
Concept
|
Caspase 3
|
|
Concept
|
Gene Regulatory Networks
|
|
Concept
|
Receptor Protein-Tyrosine Kinases
|
|
Concept
|
Receptors, CXCR4
|
|
Concept
|
eIF-2 Kinase
|
|
Concept
|
Mutation, Missense
|
|
Concept
|
Janus Kinase 1
|
|
Concept
|
Azabicyclo Compounds
|
|
Concept
|
Chemokine CXCL12
|
|
Concept
|
Immunoconjugates
|
|
Concept
|
Mucin 5AC
|
|
Concept
|
Protein Tyrosine Phosphatases
|
|
Concept
|
Reactive Oxygen Species
|
|
Concept
|
In Situ Hybridization, Fluorescence
|
|
Concept
|
Protein Structure, Secondary
|
|
Concept
|
Receptor, ErbB-3
|
|
Concept
|
Fatal Outcome
|
|
Concept
|
Oncogene Proteins, Viral
|
|
Concept
|
Intercellular Signaling Peptides and Proteins
|
|
Concept
|
Ephrin-A2
|
|
Concept
|
Vascular Endothelial Growth Factor Receptor-2
|
|
Concept
|
Consensus
|
|
Concept
|
Volvox
|
|
Concept
|
Positron-Emission Tomography
|
|
Concept
|
Atherosclerosis
|
|
Concept
|
Proteomics
|
|
Concept
|
Vascular Endothelial Growth Factors
|
|
Concept
|
Cortactin
|
|
Concept
|
Proto-Oncogene Proteins c-pim-1
|
|
Concept
|
Protein Kinase C-delta
|
|
Concept
|
Paired Box Transcription Factors
|
|
Concept
|
Proteasome Endopeptidase Complex
|
|
Concept
|
Lactams, Macrocyclic
|
|
Concept
|
Tumor Burden
|
|
Concept
|
Chromatin Immunoprecipitation
|
|
Concept
|
Mitogen-Activated Protein Kinase 3
|
|
Concept
|
Proto-Oncogene Proteins c-bcl-2
|
|
Concept
|
Area Under Curve
|
|
Concept
|
Proto-Oncogene Proteins c-raf
|
|
Concept
|
Amino Acid Substitution
|
|
Concept
|
Proto-Oncogene Proteins B-raf
|
|
Concept
|
Transcription Factor AP-1
|
|
Concept
|
Anthracyclines
|
|
Concept
|
Proto-Oncogene Proteins c-kit
|
|
Concept
|
Myokymia
|
|
Concept
|
Oligonucleotide Array Sequence Analysis
|
|
Concept
|
Stem Cell Factor
|
|
Concept
|
Receptors, Thrombopoietin
|
|
Concept
|
rac GTP-Binding Proteins
|
|
Concept
|
Amino Acid Motifs
|
|
Concept
|
Mitogen-Activated Protein Kinase Kinases
|
|
Concept
|
Receptors, Interleukin-8A
|
|
Concept
|
Bone Morphogenetic Proteins
|
|
Concept
|
Papillomaviridae
|
|
Concept
|
Fluorescein
|
|
Concept
|
Dynamin II
|
|
Concept
|
Receptors, Interleukin-8B
|
|
Concept
|
BRCA2 Protein
|
|
Concept
|
Cyclin-Dependent Kinase Inhibitor p21
|
|
Concept
|
STAT3 Transcription Factor
|
|
Concept
|
Proto-Oncogene Proteins c-ret
|
|
Concept
|
Phloretin
|
|
Concept
|
Phthalazines
|
|
Concept
|
Phosphoric Monoester Hydrolases
|
|
Concept
|
Platinum
|
|
Concept
|
Animals, Genetically Modified
|
|
Concept
|
Precipitin Tests
|
|
Concept
|
Proline
|
|
Concept
|
Promoter Regions, Genetic
|
|
Concept
|
Prostatectomy
|
|
Concept
|
Protein C
|
|
Concept
|
Chondroitin Sulfate Proteoglycans
|
|
Concept
|
Mice
|
|
Concept
|
Focal Adhesion Protein-Tyrosine Kinases
|
|
Concept
|
Focal Adhesion Kinase 1
|
|
Concept
|
Microphthalmia-Associated Transcription Factor
|
|
Concept
|
Protein Kinase C
|
|
Concept
|
Pyrazoles
|
|
Concept
|
Quinazolines
|
|
Concept
|
Hedgehog Proteins
|
|
Concept
|
Pyrimidinones
|
|
Concept
|
Pyrroles
|
|
Concept
|
Rats, Inbred Strains
|
|
Concept
|
National Cancer Institute (U.S.)
|
|
Concept
|
Saccharomyces cerevisiae
|
|
Concept
|
Sarcoma, Ewing
|
|
Concept
|
Serine
|
|
Concept
|
Serum Albumin
|
|
Concept
|
Receptor, EphB4
|
|
Concept
|
Calgranulin B
|
|
Concept
|
Structure-Activity Relationship
|
|
Concept
|
Sulfonamides
|
|
Concept
|
Taiwan
|
|
Concept
|
Flavanones
|
|
Concept
|
Threonine
|
|
Concept
|
Thrombopoietin
|
|
Concept
|
Tissue Distribution
|
|
Concept
|
Receptors, Vascular Endothelial Growth Factor
|
|
Concept
|
Meningeal Carcinomatosis
|
|
Concept
|
Shc Signaling Adaptor Proteins
|
|
Concept
|
Proto-Oncogene Proteins c-cbl
|
|
Concept
|
Rats
|
|
Concept
|
Paxillin
|
|
Concept
|
Palatine Tonsil
|
|
Concept
|
Triazoles
|
|
Concept
|
SOX9 Transcription Factor
|
|
Concept
|
PAX5 Transcription Factor
|
|
Concept
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
|
|
Concept
|
Class I Phosphatidylinositol 3-Kinases
|
|
Concept
|
TOR Serine-Threonine Kinases
|
|
Concept
|
Real-Time Polymerase Chain Reaction
|
|
Concept
|
Antibodies, Monoclonal, Humanized
|
|
Concept
|
Human Umbilical Vein Endothelial Cells
|
|
Concept
|
Insulins
|
|
Concept
|
Finches
|
|
Concept
|
Immunoprecipitation
|
|
Concept
|
Spinal Cord Neoplasms
|
|
Concept
|
Spleen
|
|
Concept
|
MAP Kinase Kinase Kinase 1
|
|
Concept
|
Adaptor Proteins, Signal Transducing
|
|
Concept
|
Temperature
|
|
Concept
|
9,10-Dimethyl-1,2-benzanthracene
|
|
Concept
|
Immunoblotting
|
|
Concept
|
Blotting, Western
|
|
Concept
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
|
|
Concept
|
Down-Regulation
|
|
Concept
|
Small Cell Lung Carcinoma
|
|
Concept
|
PTEN Phosphohydrolase
|
|
Concept
|
Recoverin
|
|
Concept
|
Multivariate Analysis
|
|
Concept
|
Logistic Models
|
|
Concept
|
CDC2 Protein Kinase
|
|
Concept
|
RNA, Antisense
|
|
Concept
|
Workload
|
|
Concept
|
Transcription Factor RelA
|
|
Concept
|
Tubulin
|
|
Concept
|
Vinblastine
|
|
Concept
|
Blotting, Southern
|
|
Concept
|
Blotting, Northern
|
|
Concept
|
Reproducibility of Results
|
|
Concept
|
Platelet Transfusion
|
|
Concept
|
Retroviridae Proteins, Oncogenic
|
|
Concept
|
Survival Rate
|
|
Concept
|
Multidetector Computed Tomography
|
|
Concept
|
Odds Ratio
|
|
Concept
|
Fusion Proteins, bcr-abl
|
|
Concept
|
Polymerase Chain Reaction
|
|
Concept
|
Retinoblastoma Protein
|
|
Concept
|
Granulocyte Colony-Stimulating Factor
|
|
Concept
|
Proto-Oncogene Proteins p21(ras)
|
|
Concept
|
Patient Selection
|
|
Concept
|
Receptor, ErbB-2
|
|
Concept
|
Thy-1 Antigens
|
|
Concept
|
Lymphoma, Large B-Cell, Diffuse
|
|
Concept
|
Remote Consultation
|
|
Concept
|
N-Acetylneuraminic Acid
|
|
Concept
|
NADPH Oxidases
|
|
Concept
|
Protein Tyrosine Phosphatase, Non-Receptor Type 6
|
|
Concept
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma
|
|
Concept
|
Receptors, Chemokine
|
|
Concept
|
Proto-Oncogene Proteins c-met
|
|
Concept
|
Mitogen-Activated Protein Kinase 1
|
|
Concept
|
Carcinoma, Pancreatic Ductal
|
|
Concept
|
Xenograft Model Antitumor Assays
|
|
Concept
|
Drug Resistance, Multiple
|
|
Concept
|
Microscopy, Atomic Force
|
|
Concept
|
Anti-HIV Agents
|
|
Concept
|
Genistein
|
|
Concept
|
Phosphatidylinositol 3-Kinases
|
|
Concept
|
Inhibitory Concentration 50
|
|
Concept
|
GTPase-Activating Proteins
|
|
Concept
|
Neuregulin-1
|
|
Concept
|
Receptor, EphA2
|
|
Concept
|
JNK Mitogen-Activated Protein Kinases
|
|
Concept
|
Receptors, Lysophosphatidic Acid
|
|
Concept
|
Tumor Suppressor Proteins
|
|
Concept
|
Crk-Associated Substrate Protein
|
|
Concept
|
Oncogene Protein v-cbl
|
|
Concept
|
STAT1 Transcription Factor
|
|
Concept
|
STAT5 Transcription Factor
|
|
Concept
|
Keratin-7
|
|
Concept
|
Keratin-20
|
|
Concept
|
Janus Kinase 2
|
|
Concept
|
RNA, Small Interfering
|
|
Concept
|
Antibodies, Monoclonal, Murine-Derived
|
|
Concept
|
Molecular Sequence Annotation
|
|
Concept
|
Peptide Hormones
|
|
Concept
|
Ribosomal Protein S6 Kinases, 70-kDa
|
|
Concept
|
Vascular Endothelial Growth Factor A
|
|
Concept
|
Intracellular Signaling Peptides and Proteins
|
|
Concept
|
Retinoblastoma-Like Protein p130
|
|
Concept
|
Cyclin-Dependent Kinase Inhibitor p27
|
|
Concept
|
Proto-Oncogene Proteins c-fyn
|
|
Concept
|
Protein Kinase C-alpha
|
|
Concept
|
fms-Like Tyrosine Kinase 3
|
|
Concept
|
Bovine papillomavirus 1
|
|
Concept
|
Kaplan-Meier Estimate
|
|
Concept
|
Protein Phosphatase 2
|
|
Concept
|
Comparative Genomic Hybridization
|
|
Concept
|
Four-Dimensional Computed Tomography
|
|
Concept
|
Antibodies, Neutralizing
|
|
Concept
|
Molecular Typing
|
|
Concept
|
Anilides
|
|
Concept
|
Anthracenes
|
|
Concept
|
Antibodies
|
|
Concept
|
Autopsy
|
|
Concept
|
Brain Neoplasms
|
|
Concept
|
Calcium-Binding Proteins
|
|
Concept
|
Chickens
|
|
Concept
|
Chromatin
|
|
Concept
|
Deoxycytidine
|
|
Concept
|
Drug Eruptions
|
|
Concept
|
Diltiazem
|
|
Concept
|
Doxorubicin
|
|
Concept
|
Enhancer Elements, Genetic
|
|
Concept
|
Epidermal Growth Factor
|
|
Concept
|
Growth Substances
|
|
Concept
|
Hyaluronic Acid
|
|
Concept
|
Luteinizing Hormone
|
|
Concept
|
Lymphocytes
|
|
Concept
|
Lymphoma, Non-Hodgkin
|
|
Concept
|
Mucins
|
|
Concept
|
Muridae
|
|
Concept
|
Neoplasm Invasiveness
|
|
Concept
|
Neuroblastoma
|
|
Concept
|
Niacinamide
|
|
Concept
|
Oligonucleotides
|
|
Concept
|
Peptides
|
|
Concept
|
Phenotype
|
|
Concept
|
Phosphoric Diester Hydrolases
|
|
Concept
|
Phylogeny
|
|
Concept
|
Pneumonectomy
|
|
Concept
|
Predictive Value of Tests
|
|
Concept
|
Prospective Studies
|
|
Concept
|
Serine Endopeptidases
|
|
Concept
|
Serum Albumin, Bovine
|
|
Concept
|
T-Lymphocytes
|
|
Concept
|
Thymus Gland
|
|
Concept
|
Restriction Mapping
|
|
Concept
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
|
|
Concept
|
Tumor Suppressor Protein p53
|
|
Concept
|
Granulocyte-Macrophage Colony-Stimulating Factor
|
|
Concept
|
Cytokines
|
|
Concept
|
Endothelins
|
|
Concept
|
Mice, SCID
|
|
Concept
|
Anticarcinogenic Agents
|
|
Concept
|
Mice, Inbred NOD
|
|
Concept
|
DNA Primers
|
|
Concept
|
Neuroendocrine Tumors
|
|
Concept
|
Mice, Inbred SENCAR
|
|
Concept
|
Hyaluronan Receptors
|
|
Concept
|
Bridged Bicyclo Compounds, Heterocyclic
|
|
Concept
|
Chemokines, CXC
|
|
Concept
|
Cyclin D1
|
|
Concept
|
Genetic Predisposition to Disease
|
|
Concept
|
U937 Cells
|
|
Concept
|
Maximum Tolerated Dose
|
|
Concept
|
Myeloid Cells
|
|
Concept
|
Potassium Channels, Voltage-Gated
|
|
Concept
|
MicroRNAs
|
|
Concept
|
Ephrins
|
|
Concept
|
Semaphorins
|
|
Concept
|
Vascular Endothelial Growth Factor Receptor-1
|
|
Concept
|
Receptors, Lysosphingolipid
|
|
Concept
|
Proto-Oncogene Proteins c-akt
|
|
Concept
|
Focal Adhesion Kinase 2
|
|
Concept
|
Endocrine Disruptors
|
|
Concept
|
TYK2 Kinase
|
|
Concept
|
Adipokines
|
|
Concept
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11
|
|
Concept
|
Protein Tyrosine Phosphatase, Non-Receptor Type 12
|
|
Concept
|
Ubiquitination
|
|
Concept
|
SOXE Transcription Factors
|
|
Concept
|
Young Adult
|
|
Concept
|
Jumonji Domain-Containing Histone Demethylases
|
|
Academic Article
|
Activation of hematopoietic growth factor signal transduction pathways by the human oncogene BCR/ABL.
|
|
Academic Article
|
The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.
|
|
Academic Article
|
Association of the Cas-like molecule HEF1 with CrkL following integrin and antigen receptor signaling in human B-cells: potential relevance to neoplastic lymphohematopoietic cells.
|
|
Academic Article
|
Role of serum tumor markers CA 125 and CEA in non-small cell lung cancer.
|
|
Academic Article
|
The BCR/ABL oncogene alters the chemotactic response to stromal-derived factor-1alpha.
|
|
Academic Article
|
Chemokine receptors CXCR-1/2 activate mitogen-activated protein kinase via the epidermal growth factor receptor in ovarian cancer cells.
|
|
Academic Article
|
Molecular abnormalities in lung cancer.
|
|
Academic Article
|
Expression of the focal adhesion protein paxillin in lung cancer and its relation to cell motility.
|
|
Academic Article
|
The noncatalytic domain of protein-tyrosine phosphatase-PEST targets paxillin for dephosphorylation in vivo.
|
|
Academic Article
|
A cdc15-like adaptor protein (CD2BP1) interacts with the CD2 cytoplasmic domain and regulates CD2-triggered adhesion.
|
|
Academic Article
|
ATP6S1 elicits potent humoral responses associated with immune-mediated tumor destruction.
|
|
Academic Article
|
Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells.
|
|
Academic Article
|
CD2 molecules redistribute to the uropod during T cell scanning: implications for cellular activation and immune surveillance.
|
|
Academic Article
|
Role of the cytoskeletal protein paxillin in oncogenesis.
|
|
Academic Article
|
Vaccination with irradiated autologous tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor augments antitumor immunity in some patients with metastatic non-small-cell lung carcinoma.
|
|
Academic Article
|
Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer.
|
|
Academic Article
|
Circulating tumor cells and serum tumor biomarkers in small cell lung cancer.
|
|
Academic Article
|
Cell motility, adhesion, homing, and migration assays in the studies of tyrosine kinases.
|
|
Academic Article
|
Role of receptor tyrosine kinases in lung cancer.
|
|
Academic Article
|
Gemcitabine-induced radiation recall.
|
|
Academic Article
|
Activated c-Met signals through PI3K with dramatic effects on cytoskeletal functions in small cell lung cancer.
|
|
Academic Article
|
Flow cytometric determination of lipid peroxidation using fluoresceinated phosphoethanolamine.
|
|
Academic Article
|
c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
|
|
Academic Article
|
Fibronectin enhances viability and alters cytoskeletal functions (with effects on the phosphatidylinositol 3-kinase pathway) in small cell lung cancer.
|
|
Academic Article
|
2-methoxyestradiol alters cell motility, migration, and adhesion.
|
|
Academic Article
|
Molecular alterations in lung cancer. Impact on prognosis.
|
|
Academic Article
|
Use of temozolomide with other cytotoxic chemotherapy in the treatment of patients with recurrent brain metastases from lung cancer.
|
|
Academic Article
|
Small-cell cancers, and an unusual reaction to chemotherapy. Case 1. Extrapulmonary small-cell carcinoma arising in the prostate.
|
|
Academic Article
|
Therapeutic targeting of the receptor tyrosine kinase Met.
|
|
Academic Article
|
Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer.
|
|
Academic Article
|
Novel therapies in lung cancer.
|
|
Academic Article
|
Expression of Siva-1 protein or its putative amphipathic helical region enhances cisplatin-induced apoptosis in breast cancer cells: effect of elevated levels of BCL-2.
|
|
Academic Article
|
A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenografts.
|
|
Academic Article
|
Epidermal growth factor receptor mutations and susceptibility to targeted therapy in lung cancer.
|
|
Academic Article
|
Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas.
|
|
Academic Article
|
A review of topoisomerase inhibition in lung cancer.
|
|
Academic Article
|
c-Met: structure, functions and potential for therapeutic inhibition.
|
|
Academic Article
|
Recent advances in the molecular biology, diagnosis and novel therapies for various small blue cell tumors.
|
|
Academic Article
|
MET as a target for treatment of chest tumors.
|
|
Academic Article
|
The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.
|
|
Academic Article
|
Lymphatic vessel density is not associated with lymph node metastasis in non-small cell lung carcinoma.
|
|
Academic Article
|
Receptor tyrosine kinases and inhibitors in lung cancer.
|
|
Academic Article
|
Concerted potent humoral immune responses to autoantigens are associated with tumor destruction and favorable clinical outcomes without autoimmunity.
|
|
Academic Article
|
Expression and mutational analysis of MET in human solid cancers.
|
|
Academic Article
|
Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesothelioma.
|
|
Academic Article
|
CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinases.
|
|
Academic Article
|
c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion.
|
|
Academic Article
|
The clinical presentation and prognostic factors for intrahepatic and extrahepatic cholangiocarcinoma in a tertiary care centre.
|
|
Academic Article
|
Rapid and dramatic radiographic and clinical response to an ALK inhibitor (crizotinib, PF02341066) in an ALK translocation-positive patient with non-small cell lung cancer.
|
|
Academic Article
|
The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation.
|
|
Academic Article
|
Chemotherapy and high dose radiotherapy followed by resection for locally advanced nonsmall cell lung cancers.
|
|
Academic Article
|
Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma.
|
|
Academic Article
|
Fyn is downstream of the HGF/MET signaling axis and affects cellular shape and tropism in PC3 cells.
|
|
Academic Article
|
Non-receptor tyrosine kinase inhibitors in lung cancer.
|
|
Academic Article
|
Takotsubo cardiomyopathy in a patient with squamous cell esophageal carcinoma.
|
|
Academic Article
|
Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer.
|
|
Academic Article
|
Characterization of NOL7 gene point mutations, promoter methylation, and protein expression in cervical cancer.
|
|
Academic Article
|
Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.
|
|
Academic Article
|
Overexpression of the µ-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis.
|
|
Academic Article
|
Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer.
|
|
Academic Article
|
Hemostatic abnormalities in untreated cancer: incidence and correlation with thrombotic and hemorrhagic complications.
|
|
Academic Article
|
The effects of monensin on membrane lipids of cultured human skin fibroblasts.
|
|
Academic Article
|
Molecular cloning of human paxillin, a focal adhesion protein phosphorylated by P210BCR/ABL.
|
|
Academic Article
|
Melanoma proteoglycan modifies gene expression to stimulate tumor cell motility, growth, and epithelial-to-mesenchymal transition.
|
|
Academic Article
|
The database of chromosome imbalance regions and genes resided in lung cancer from Asian and Caucasian identified by array-comparative genomic hybridization.
|
|
Academic Article
|
Control of bleeding in patients with immune and nonimmune thrombocytopenia with aminocaproic acid.
|
|
Academic Article
|
Targeted and cytotoxic therapy in coordinated sequence (TACTICS): erlotinib, bevacizumab, and standard chemotherapy for non-small-cell lung cancer, a phase II trial.
|
|
Academic Article
|
Altered membrane fluidity in rat hepatocytes during endotoxic shock.
|
|
Academic Article
|
Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion.
|
|
Academic Article
|
Novel oncogenic mutations of CBL in human acute myeloid leukemia that activate growth and survival pathways depend on increased metabolism.
|
|
Academic Article
|
Novel functional germline variants in the VEGF receptor 2 gene and their effect on gene expression and microvessel density in lung cancer.
|
|
Academic Article
|
Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis.
|
|
Academic Article
|
Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of The American Association for Thoracic Surgery Task Force for Lung Cancer Screening and Surveillance.
|
|
Academic Article
|
The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups.
|
|
Academic Article
|
Phase II study of the multitargeted tyrosine kinase inhibitor XL647 in patients with non-small-cell lung cancer.
|
|
Academic Article
|
Three-dimensional stereoscopic volume rendering of malignant pleural mesothelioma.
|
|
Academic Article
|
Role of the adapter protein CRKL in signal transduction of normal hematopoietic and BCR/ABL-transformed cells.
|
|
Academic Article
|
Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma.
|
|
Academic Article
|
Detection and analysis of lung cancer cells from body fluids using a rare event imaging system.
|
|
Academic Article
|
Molecular and cellular biology of small cell lung cancer.
|
|
Academic Article
|
Unusual problems in breast cancer and a rare lung cancer case. Case 4. Primary lymphoepithelioma-like carcinoma of the lung.
|
|
Academic Article
|
A novel small molecule met inhibitor induces apoptosis in cells transformed by the oncogenic TPR-MET tyrosine kinase.
|
|
Academic Article
|
Mechanisms of metastasis as related to receptor tyrosine kinases in small-cell lung cancer.
|
|
Academic Article
|
Key signaling pathways and targets in lung cancer therapy.
|
|
Academic Article
|
Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
|
|
Academic Article
|
C. elegans as a model organism for in vivo screening in cancer: effects of human c-Met in lung cancer affect C. elegans vulva phenotypes.
|
|
Academic Article
|
Phase II study of amrubicin as second-line therapy in patients with platinum-refractory small-cell lung cancer.
|
|
Academic Article
|
Paxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic disease.
|
|
Academic Article
|
RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma.
|
|
Academic Article
|
Role of MetMAb (OA-5D5) in c-MET active lung malignancies.
|
|
Academic Article
|
Critical role for the receptor tyrosine kinase EPHB4 in esophageal cancers.
|
|
Academic Article
|
The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target.
|
|
Academic Article
|
Evidence-based role of bevacizumab in non-small cell lung cancer.
|
|
Academic Article
|
EphB4 as a therapeutic target in mesothelioma.
|
|
Academic Article
|
Lipopolysaccharide-induced phosphorylation of c-Met tyrosine residue 1003 regulates c-Met intracellular trafficking and lung epithelial barrier function.
|
|
Academic Article
|
Paxillin mutations affect focal adhesions and lead to altered mitochondrial dynamics: relevance to lung cancer.
|
|
Academic Article
|
Targeted agents in non-small cell lung cancer therapy: What is there on the horizon?
|
|
Academic Article
|
Molecular biomarkers for future screening of lung cancer.
|
|
Academic Article
|
Analysis of 1,115 patients tested for MET amplification and therapy response in the MD Anderson Phase I Clinic.
|
|
Academic Article
|
MET and PI3K/mTOR as a potential combinatorial therapeutic target in malignant pleural mesothelioma.
|
|
Academic Article
|
Brain metastases in non-small-cell lung cancer: better outcomes through current therapies and utilization of molecularly targeted approaches.
|
|
Academic Article
|
Mitochondrial dynamics: biology and therapy in lung cancer.
|
|
Academic Article
|
O-6-methylguanine-deoxyribonucleic acid methyltransferase methylation enhances response to temozolomide treatment in esophageal cancer.
|
|
Academic Article
|
Dramatic antitumor effects of the dual MET/RON small-molecule inhibitor LY2801653 in non-small cell lung cancer.
|
|
Academic Article
|
Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancer.
|
|
Academic Article
|
Geographic variation in radiologist capacity and widespread implementation of lung cancer CT screening.
|
|
Academic Article
|
Fibroblast growth factor signaling and inhibition in non-small cell lung cancer and their role in squamous cell tumors.
|
|
Academic Article
|
AXL mediates resistance to cetuximab therapy.
|
|
Academic Article
|
Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy.
|
|
Academic Article
|
Molecularly targeted therapies in non-small-cell lung cancer annual update 2014.
|
|
Academic Article
|
Nuclear epidermal growth factor receptor is a functional molecular target in triple-negative breast cancer.
|
|
Academic Article
|
AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma.
|
|
Academic Article
|
A new PET/CT volumetric prognostic index for non-small cell lung cancer.
|
|
Academic Article
|
Engineering Synthetic Antibody Inhibitors Specific for LD2 or LD4 Motifs of Paxillin.
|
|
Academic Article
|
Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors.
|
|
Academic Article
|
Lung cancer-a fractal viewpoint.
|
|
Academic Article
|
ROS1 rearranged non-small cell lung cancer brain metastases respond to low dose radiotherapy.
|
|
Academic Article
|
Role played by paxillin and paxillin tyrosine phosphorylation in hepatocyte growth factor/sphingosine-1-phosphate-mediated reactive oxygen species generation, lamellipodia formation, and endothelial barrier function.
|
|
Academic Article
|
Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancer.
|
|
Academic Article
|
Systemic therapies in the treatment of non-small-cell lung cancer brain metastases.
|
|
Academic Article
|
Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer.
|
|
Academic Article
|
Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer.
|
|
Academic Article
|
Prognostic and Predictive Value in KRAS in Non-Small-Cell Lung Cancer: A Review.
|
|
Academic Article
|
FAK and paxillin, two potential targets in pancreatic cancer.
|
|
Academic Article
|
Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment.
|
|
Academic Article
|
Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to Cetuximab.
|
|
Academic Article
|
PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma.
|
|
Academic Article
|
DIFFERENTIAL SERUM LEVEL OF SPECIFIC HAPTOGLOBIN ISOFORMS IN SMALL CELL LUNG CANCER.
|
|
Academic Article
|
Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial.
|
|
Academic Article
|
Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer.
|
|
Academic Article
|
Expression and mutational analysis of c-CBL and its relationship to the MET receptor in head and neck squamous cell carcinoma.
|
|
Academic Article
|
A phase I study of XL184, a RET, VEGFR2, and MET kinase inhibitor, in patients (pts) with advanced malignancies, including pts with medullary thyroid cancer (MTC).
|
|
Academic Article
|
Activity of XL647 in clinically selected NSCLC patients (pts) enriched for the presence of EGFR mutations: Results from Phase 2.
|
|
Academic Article
|
Complete Pathologic Response When Adding Pembrolizumab to Neoadjuvant Chemotherapy in Stage IIIA Non-Small-Cell Lung Cancer.
|
|
Academic Article
|
Effective osimertinib treatment in a patient with discordant T790 M mutation detection between liquid biopsy and tissue biopsy.
|
|
Academic Article
|
Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBL.
|
|
Academic Article
|
Correction: AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma.
|
|
Academic Article
|
Correction: Genomic mutation-driven metastatic breast cancer therapy: a single center experience.
|
|
Academic Article
|
Acute myeloid leukemia cells require 6-phosphogluconate dehydrogenase for cell growth and NADPH-dependent metabolic reprogramming.
|
|
Academic Article
|
EphB4: A promising target for upper aerodigestive malignancies.
|
|
Academic Article
|
2'-Hydroxyflavanone inhibits in vitro and in vivo growth of breast cancer cells by targeting RLIP76.
|
|
Academic Article
|
Metastasis of breast tumor cells to brain is suppressed by targeting RLIP alone and in combination with 2'-Hydroxyflavanone.
|
|
Academic Article
|
Empowering survivors after colorectal and lung cancer treatment: Pilot study of a Self-Management Survivorship Care Planning intervention.
|
|
Academic Article
|
Untying the gordion knot of targeting MET in cancer.
|
|
Academic Article
|
Responses to Alectinib in ALK-rearranged Papillary Renal Cell Carcinoma.
|
|
Academic Article
|
A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer.
|
|
Academic Article
|
RLIP inhibition suppresses breast-to-lung metastasis.
|
|
Academic Article
|
Anaplastic Lymphoma Kinase (ALK)-positive Tumors: Clinical, Radiographic and Molecular Profiles, and Uncommon Sites of Metastases in Patients With Lung Adenocarcinoma.
|
|
Academic Article
|
Prolonged Pharmacokinetic Interaction Between Capecitabine and a CYP2C9 Substrate, Celecoxib.
|
|
Academic Article
|
Notch signaling in breast cancer: From pathway analysis to therapy.
|
|
Academic Article
|
Ubiquitin-specific protease 22 is critical to in vivo angiogenesis, growth and metastasis of non-small cell lung cancer.
|
|
Academic Article
|
Association of TGF-ß1 Polymorphisms with Breast Cancer Risk: A Meta-Analysis of Case-Control Studies †.
|
|
Academic Article
|
Radiomic prediction of mutation status based on MR imaging of lung cancer brain metastases.
|
|
Academic Article
|
Phase I Dose-Escalation and -Expansion Study of Telisotuzumab (ABT-700), an Anti-c-Met Antibody, in Patients with Advanced Solid Tumors.
|
|
Academic Article
|
The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping.
|
|
Academic Article
|
Targeting RLIP with CRISPR/Cas9 controls tumor growth.
|
|
Academic Article
|
AXL Mediates Cetuximab and Radiation Resistance Through Tyrosine 821 and the c-ABL Kinase Pathway in Head and Neck Cancer.
|
|
Academic Article
|
Role of immunotherapy and co-mutations on KRAS-mutant non-small cell lung cancer survival.
|
|
Academic Article
|
Rapid progression of disease from immunotherapy following targeted therapy: insights into treatment management and sequence.
|
|
Academic Article
|
Prolonged survival and response to tepotinib in a non-small-cell lung cancer patient with brain metastases harboring MET exon 14 mutation: a research report.
|
|
Academic Article
|
Salmonella-Based Therapy Targeting Indoleamine 2,3-Dioxygenase Restructures the Immune Contexture to Improve Checkpoint Blockade Efficacy.
|
|
Academic Article
|
Acquired Resistance to PD-1/PD-L1 Blockade in Lung Cancer: Mechanisms and Patterns of Failure.
|
|
Academic Article
|
Prevention of mammary carcinogenesis in MMTV-neu mice by targeting RLIP.
|
|
Academic Article
|
RLIP depletion induces apoptosis associated with inhibition of JAK2/STAT3 signaling in melanoma cells.
|
|
Academic Article
|
Predicting Survival Duration With MRI Radiomics of Brain Metastases From Non-small Cell Lung Cancer.
|
|
Academic Article
|
Germline mutations and age at onset of lung adenocarcinoma.
|
|
Academic Article
|
Evolution of core archetypal phenotypes in progressive high grade serous ovarian cancer.
|
|
Academic Article
|
MicroRNA-1: Diverse role of a small player in multiple cancers.
|
|
Academic Article
|
Essential role of the histone lysine demethylase KDM4A in the biology of malignant pleural mesothelioma (MPM).
|
|
Academic Article
|
Immune Checkpoint Inhibitor-Induced Myocarditis with Myositis/Myasthenia Gravis Overlap Syndrome: A Systematic Review of Cases.
|
|
Academic Article
|
Targeting CA-125 Transcription by Development of a Conditionally Replicative Adenovirus for Ovarian Cancer Treatment.
|
|
Academic Article
|
JNJ-64041757 (JNJ-757), a Live, Attenuated, Double-Deleted Listeria monocytogenes-Based Immunotherapy in Patients With NSCLC: Results From Two Phase 1 Studies.
|
|
Academic Article
|
Dynamic Phenotypic Switching and Group Behavior Help Non-Small Cell Lung Cancer Cells Evade Chemotherapy.
|
|
Academic Article
|
Novel Therapeutic Targets and Immune Dysfunction in Malignant Pleural Mesothelioma.
|
|
Academic Article
|
Intrinsically Disordered Proteins: Critical Components of the Wetware.
|
|
Academic Article
|
Report of the First International Symposium on NUT Carcinoma.
|
|
Academic Article
|
Intrinsic disorder, extraterrestrial peptides, and prebiotic life on the earth.
|
|
Academic Article
|
A Systems Biology Approach for Addressing Cisplatin Resistance in Non-Small Cell Lung Cancer.
|
|
Academic Article
|
Overcoming Barriers to Tobacco Cessation and Lung Cancer Screening among Racial and Ethnic Minority Groups and Underserved Patients in Academic Centers and Community Network Sites: The City of Hope Experience.
|
|
Academic Article
|
A Closer Look at EGFR Inhibitor Resistance in Non-Small Cell Lung Cancer through the Lens of Precision Medicine.
|
|
Concept
|
Cell Self Renewal
|
|
Concept
|
Pemetrexed
|
|
Concept
|
Celecoxib
|
|
Concept
|
Bevacizumab
|
|
Concept
|
Imatinib Mesylate
|
|
Concept
|
Cetuximab
|
|
Concept
|
Capecitabine
|
|
Concept
|
Bortezomib
|
|
Concept
|
Erlotinib Hydrochloride
|
|
Concept
|
Origin of Life
|
|
Concept
|
Alpha-Ketoglutarate-Dependent Dioxygenase FTO
|
|
Concept
|
Antagomirs
|
|
Concept
|
PAX3 Transcription Factor
|
|
Concept
|
Positron Emission Tomography Computed Tomography
|
|
Concept
|
Ku Autoantigen
|
|
Concept
|
Forkhead Box Protein M1
|
|
Concept
|
PAX8 Transcription Factor
|
|
Concept
|
Src Homology 2 Domain-Containing, Transforming Protein 1
|
|
Concept
|
PAX6 Transcription Factor
|
|
Concept
|
Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases
|
|
Concept
|
Protein Domains
|
|
Concept
|
Proof of Concept Study
|
|
Concept
|
Fanconi Anemia Complementation Group N Protein
|
|
Concept
|
Cell Surface Display Techniques
|
|
Concept
|
T-Lymphoma Invasion and Metastasis-inducing Protein 1
|
|
Concept
|
Inhibitor of Growth Protein 1
|
|
Concept
|
c-Mer Tyrosine Kinase
|
|
Concept
|
MCF-7 Cells
|
|
Concept
|
Carcinogenesis
|
|
Concept
|
Protein Kinase C beta
|
|
Concept
|
Cytochrome P-450 CYP2C9
|
|
Concept
|
ErbB Receptors
|
|
Grant
|
Role of Paxillin in Lung Cancer
|
|
Grant
|
Novel Targeted Therapy in Pancreatic Cancer
|
|
Grant
|
Studies of a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC)
|
|
Grant
|
PAXILLIN--AN ONCOGENE ACTIVATED PROTEIN
|
|
Academic Article
|
Dual Axl/MerTK inhibitor INCB081776 creates a proinflammatory tumor immune microenvironment and enhances anti-PDL1 efficacy in head and neck cancer.
|
|
Academic Article
|
LSD1-targeted therapy-a multi-purpose key to unlock immunotherapy in small cell lung cancer.
|
|
Academic Article
|
Clinical Network Systems Biology: Traversing the Cancer Multiverse.
|
|
Academic Article
|
Stereotactic Body Radiation Therapy for Oligoprogressive and Oligorecurrent Non-Small-Cell Lung Cancer.
|
|
Academic Article
|
On the Virtues of "Team Medicine"-A City of Hope Perspective.
|
|
Academic Article
|
Selpercatinib and Pralsetinib Induced Chylous Ascites in RET-Rearranged Lung Adenocarcinoma: A Case Series.
|
|
Academic Article
|
Phase II Trial of Lung Chemoembolization.
|
|
Academic Article
|
Regression of ovarian cancer xenografts by depleting or inhibiting RLIP.
|